Aclaris Therapeutics Q3 net income was $18.51 million below zero versus $23.7 million estimate
ACRS•Aclaris Therapeutics reported Q3 net income of negative $18.51 million, compared with an IBES estimate of negative $23.7 million, and revenue of $1.481 million versus an estimate of $1.3 million.
1. Q3 results
Aclaris Therapeutics reported Q3 net income of negative $18.51 million, compared with an IBES estimate of negative $23.7 million. Revenue was $1.481 million, versus an IBES estimate of $1.3 million.
